Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Gardasil HPV vaccine

Phase 3Vaccine

LLondon School of Hygiene and Tropical Medicine

1

Indications

2

Total Trials

1

Active Trials

0

Competitors

Pipeline

Status by Indication[3][1]

Indication

HPV InfectionRecruiting

HPV InfectionPhase 3

Recruiting

Timeline

Expected Milestones

Q4 2026

ApprovedRecruiting

HPV Infection

NCT04953130

Clinical

Trials by Indication[1]

HPV Vaccination1 trial

Delivery, Uptake and Acceptability of HPV Vaccination in Tanzanian Girls

Completed·LLondon School of Hygiene and Tropical Medicine·Phase 4·NCT01173900·5,532 enrolled

HPV Infection1 trial

Adding Male Single Dose HPV Vaccination to Female HPV Vaccination in Tanzania

Recruiting·LLondon School of Hygiene and Tropical Medicine·Approved·NCT04953130·10,400 enrolled

Sources

References

[1]
ClinicalTrials.gov — 2 trial records for Gardasil HPV vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Gardasil HPV vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Gardasil HPV vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — London School of Hygiene and Tropical Medicine company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Phase 3[1]
Company: LLondon School of Hygiene and Tropical Medicine

Related News